Al-78898A

DRUG2 trials

Sponsors

Alcon Research

Conditions

Exudative Age-Related Macular DegenerationGeographic Atrophy

Phase 2

Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration

CompletedNCT01157065

Alcon ResearchExudative Age-Related Macular Degeneration

Start: 2011-06-30End: 2012-04-30Updated: 2013-06-04

A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)

TerminatedNCT01603043

Alcon ResearchGeographic Atrophy

Start: 2012-06-30End: 2012-11-30Updated: 2014-01-20